Study ID: DR-DSG-302
Study Title
- A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021
Teva Identifier
- DR-DSG-302
ClinicalTrials.gov Identifier
- NCT00544882
Study Status
- Completed
Trial Condition(s)
- Healthy
Interventions
- Drug: DR-1021 | Drug: Mircetteֲ® | Drug: Karivaֲ®
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female
Age Range
- 18 Years to 35 Years
Trial Duration
- 10/01/2007 - 03/01/2008
Phase
- Phase 3
Study Type
Interventional